Cancer Institute NSW

Kendelle Murphy, Frances Byrne, Antoine de Weck, Brooke Pereira, Abba Habibalahi, Benjamin Daniels and Ben Smith

Medicine, science and biomedical engineering academics receive grants to explore new approaches to cancer treatment.

Unidentifiable patients receive chemotherapy treatment in a hospital

A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.

Professor Paul Timpson; Professor David Thomas; Associate Professor Phoebe Phillips and Professor David Goldstein; and Associate Professor Marina Pajic.

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.

17_unsw_conjoint_lecturer_dr_david_gallego_ortega_based_at_the_garvan_institute_of_medical_research.jpg

UNSW researchers working on some of the most aggressive cancers including neuroblastoma, leukaemia, and pancreatic and breast tumours have received major backing from The Cancer Institute NSW.

08_cancer_research.jpg

UNSW researchers working to fast-track cancer treatments from the laboratory to the bedside have received major backing in the latest round of funding from The Cancer Institute NSW.

4 CINSW grants 1

UNSW research into childhood cancer and treatments for patients with nerve damage has received major backing in the latest round of funding from The Cancer Institute NSW.